ROTH Capital Partners' Joseph Pantginis Interviewed by The Life Sciences Report Apr 28, 2016 09:00AM
Roth Keeps Positive View on Rexahn (RNN) Following Equity Raise; Affirms at 'Buy' Feb 26, 2016 11:34AM
First Data from Rexahn's (RNN) Archexin Phase 2a Release; Appears Right on Track - Roth Nov 6, 2015 09:41AM
Roth Affirms Rexahn Pharma (RNN) at 'Buy'; Broad POC Program Initiation, Archexin Data in mRCC on Tap Nov 3, 2015 11:49AM
Streetinsider.com's Hot Lunchtime Reads 9/28: (BID) (GALE) (AAPL) (QSR) Sep 28, 2015 12:16PM


Sep 28, 2015 11:54AM Roth Capital Reiterates Buy on Rexahn Pharma (RNN) as Data Flows Begin
Sep 28, 2015 11:51AM Rexahn Pharma (RNN) Starts Data Flow on RX-5902, RX-3117; Roth Capital Affirms at 'Buy'
Aug 10, 2015 02:09PM Roth Capital Positive on Rexahn Pharma (RNN) Following Q2 Report; Upcoming Supinoxin, RX-3117 Phase 1 Data is Key
May 11, 2015 03:10PM Rexahn (RNN) Valuation Remains Compelling at Supinoxin, RX-3117 Phase 1 Milestones Near - Roth Capital
May 11, 2015 09:00AM Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update
Mar 17, 2015 02:08PM Roth Affirms Rexahn (RNN) at 'Buy' Following FY14 Results; Supinoxin, RX-3117 Remain in Focus
Mar 17, 2015 09:04AM Rexahn Pharma (RNN) Reports Wider Loss for 2014; Updates on Clinical Development Programs
Mar 17, 2015 09:00AM Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Pipeline Update
Sep 24, 2014 10:57AM Roth 'Encouraged' by Rexahn's (RNN) RX-3117 Receiving FDA Orphan Drug Designation; Offers Commentary
Aug 14, 2014 09:45AM Roth Affirms Rexahn (RNN) at 'Buy'; Comments on Q2 Results, Pipeline Update
Jul 18, 2014 10:56AM Roth Encouraged by Progress with Supinoxin; Maintains 'Buy Rating on Rexahn Pharma (RNN)
May 15, 2014 08:14AM Roth Affirms Rexahn (RNN) at 'Buy'; Things Shaping Up for Solid Second-Half 2014
Mar 24, 2014 02:56PM Stronger-than-Expected FY13 Results Set Rexahn Pharma (RNN) Up for Promising FY14 - Analyst
Jan 24, 2014 11:39AM Rexahn Pharma (RNN) Rises Back Above $1 Level with Volume
Jan 15, 2014 09:00AM Rexahn Pharma (RNN) Announces $20M Registered Direct Offering
Jan 9, 2014 02:58PM Notable 52-Week Highs and Lows of the Day 01/09: (RNN) (M) (WAG) High; (MRGE) (LULU) Low
Jan 9, 2014 01:01PM Roth Capital Starts Rexahn Pharma (RNN) at Buy; Pieces in Place for Ground-Floor Opportunity
Jan 9, 2014 10:58AM Notable Analyst Rating Changes 01/09: (JCP) (M) (AET) Upgraded; (BWLD) (S) (NVDA) Downgraded
Jan 9, 2014 09:39AM Pre-Open Stock Movers 1/9: (ICPT) (CRDC) (F) Higher; (YRCW) (FDO) (PIR) Lower (more...)
Jan 9, 2014 08:19AM Roth Capital Starts Rexahn Pharmaceuticals Inc. (RNN) at Buy